205 related articles for article (PubMed ID: 2440627)
21. Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia.
Nobile-Orazio E; Francomano E; Daverio R; Barbieri S; Marmiroli P; Manfredini E; Carpo M; Moggio M; Legname G; Baldini L
Ann Neurol; 1989 Oct; 26(4):543-50. PubMed ID: 2479332
[TBL] [Abstract][Full Text] [Related]
22. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
[TBL] [Abstract][Full Text] [Related]
23. Specificity and idiotype of M-proteins that react with MAG in patients with neuropathy.
Saito T; Sherman WH; Latov N
J Immunol; 1983 Jun; 130(6):2496-8. PubMed ID: 6189889
[No Abstract] [Full Text] [Related]
24. Specificity of human IgM M-proteins that bind to myelin-associated glycoprotein: peptide mapping, deglycosylation, and competitive binding studies.
Shy ME; Vietorisz T; Nobile-Orazio E; Latov N
J Immunol; 1984 Nov; 133(5):2509-12. PubMed ID: 6207233
[TBL] [Abstract][Full Text] [Related]
25. Molecular characteristics of the epitope in myelin-associated glycoprotein that is recognized by a monoclonal IgM in human neuropathy patients.
Frail DE; Edwards AM; Braun PE
Mol Immunol; 1984 Aug; 21(8):721-5. PubMed ID: 6205257
[TBL] [Abstract][Full Text] [Related]
26. Molecular specificity of L2 monoclonal antibodies that bind to carbohydrate determinants of neural cell adhesion molecules and their resemblance to other monoclonal antibodies recognizing the myelin-associated glycoprotein.
Noronha AB; Ilyas A; Antonicek H; Schachner M; Quarles RH
Brain Res; 1986 Oct; 385(2):237-44. PubMed ID: 2430667
[TBL] [Abstract][Full Text] [Related]
27. The species distribution of nervous system antigens that react with anti-myelin-associated glycoprotein antibodies.
O'Shannessy DJ; Willison HJ; Inuzuka T; Dobersen MJ; Quarles RH
J Neuroimmunol; 1985 Sep; 9(5):255-68. PubMed ID: 2410452
[TBL] [Abstract][Full Text] [Related]
28. Reactivity with neural cell adhesion molecules in sera from patients with demyelinating diseases.
Poltorak M; Steck AJ; Schachner M
Neurosci Lett; 1986 Apr; 65(2):199-203. PubMed ID: 2423924
[TBL] [Abstract][Full Text] [Related]
29. Treatment of patients with neuropathy and anti-MAG IgM M-proteins.
Nobile-Orazio E; Baldini L; Barbieri S; Marmiroli P; Spagnol G; Francomano E; Scarlato G
Ann Neurol; 1988 Jul; 24(1):93-7. PubMed ID: 2458065
[TBL] [Abstract][Full Text] [Related]
30. [A case of IgM paraproteinemic polyneuropathy complicated with serum anti-myelin-associated glycoprotein and anti-GM1 antibodies].
Tagaya N; Saito T; Fujioka T; Honda M; Kinoshita M
Rinsho Shinkeigaku; 1993 Mar; 33(3):322-6. PubMed ID: 7687527
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic value of the anti-IgM SGPG Elisa (Bühlmann laboratories AG) in 147 sera with a monoclonal IgM anti-MAG/SGPG antibody-associated neuropathy].
Caudie C; Bouhour F; Petiot P; Gonnaud PM; Antoine JC; Vial C
Ann Biol Clin (Paris); 2007; 65(4):369-75. PubMed ID: 17627917
[TBL] [Abstract][Full Text] [Related]
32. Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein.
Steck AJ; Murray N; Meier C; Page N; Perruisseau G
Neurology; 1983 Jan; 33(1):19-23. PubMed ID: 6184645
[TBL] [Abstract][Full Text] [Related]
33. Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes.
Ilyas AA; Dalakas MC; Brady RO; Quarles RH
Brain Res; 1986 Oct; 385(1):1-9. PubMed ID: 2429733
[TBL] [Abstract][Full Text] [Related]
34. NK cell function in a patient with IgM monoclonal antibody against myelin-associated glycoprotein.
Sriram S; Lanier L
Neurology; 1986 Apr; 36(4):566-8. PubMed ID: 2421200
[TBL] [Abstract][Full Text] [Related]
35. Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein.
Melmed C; Frail D; Duncan I; Braun P; Danoff D; Finlayson M; Stewart J
Neurology; 1983 Nov; 33(11):1397-405. PubMed ID: 6314178
[TBL] [Abstract][Full Text] [Related]
36. Human natural killer cell activity is reduced by treatment of anti-myelin-associated glycoprotein (MAG) monoclonal mouse IgM antibody and complement.
Tanaka M; Nishizawa M; Inuzuka T; Baba H; Sato S; Miyatake T
J Neuroimmunol; 1985 Dec; 10(2):115-27. PubMed ID: 2415553
[TBL] [Abstract][Full Text] [Related]
37. Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins.
Ilyas AA; Quarles RH; Dalakas MC; Brady RO
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6697-700. PubMed ID: 2413445
[TBL] [Abstract][Full Text] [Related]
38. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.
Nobile-Orazio E; Manfredini E; Carpo M; Meucci N; Monaco S; Ferrari S; Bonetti B; Cavaletti G; Gemignani F; Durelli L
Ann Neurol; 1994 Sep; 36(3):416-24. PubMed ID: 8080249
[TBL] [Abstract][Full Text] [Related]
39. IgM paraproteinaemia, polyneuropathy and myelin-associated glycoprotein (MAG).
Gregson NA; Leibowitz S
Neuropathol Appl Neurobiol; 1985; 11(5):329-47. PubMed ID: 2417153
[No Abstract] [Full Text] [Related]
40. Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide.
Ilyas AA; Cook SD; Dalakas MC; Mithen FA
J Neuroimmunol; 1992 Mar; 37(1-2):85-92. PubMed ID: 1372333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
